4//SEC Filing
MusclePharm Corp 4
Accession 0001144204-16-139012
CIK 0001415684operating
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 5:13 PM ET
Size
6.2 KB
Accession
0001144204-16-139012
Insider Transaction Report
Form 4
MusclePharm CorpMSLP
Drexler Ryan Charles
Director10% Owner
Transactions
- Award
Common Stock
2016-12-08+550,000→ 581,924 total
Holdings
- 1,499,408(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]On December 8, 2016, Mr. Drexler was granted 550,000 shares of restricted stock pursuant to the Amended and Restated Executive Employment Agreement between MusclePharm Corporation and Mr. Drexler, dated November 18, 2016. The restricted stock vests in full upon the first anniversary of the grant date.
- [F2]Represents shares of common stock held by Consac LLC ("Consac"). Mr. Drexler is the Chief Executive Officer of Consac and may be deemed to be the indirect beneficial owner (as that term is defined under Rule 13d-3 of the Securities Exchange Act) of the common stock that Consac beneficially owns. Mr. Drexler has the power to direct the voting and disposition of the Issuer's common stock that Consac beneficially owns.
Documents
Issuer
MusclePharm Corp
CIK 0001415684
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001415684
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 5:13 PM ET
- Size
- 6.2 KB